Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Diabetes Mellitus, Type 2 · Pharmacokinetic trial

Boehringer Ingelheim

Boehringer Ingelheim clinical programs — 193 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
Binger Straße, Ingelheim am Rhein, Rhineland-Palatinate 55218, DE HQ
46,699 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Binger Straße, Ingelheim am Rhein, Rhineland-Palatinate 55218, DE
Employees
46,699
Programs
193
Drugs
113
Patents
25
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Programs

Boehringer Ingelheim projects

193 ClinicalTrials.gov programs sponsored by Boehringer Ingelheim.

Boehringer Ingelheim has 193 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

193 programs

Clinical programs

Page 4 of 5

  1. 1480-0001

    Boehringer Ingelheim

    Advanced solid tumours

    phase 1 other active

    1 trial

  2. 1485-0013

    Boehringer Ingelheim

    Healthy volunteer trial

    phase 1 other active

    1 trial

  3. 1490-0006

    Boehringer Ingelheim

    Healthy volunteer trial

    phase 1 other active

    1 trial

  4. 1493-0008

    Boehringer Ingelheim

    Healthy volunteer trial

    phase 1 other active

    1 trial

  5. 1501-0002

    Boehringer Ingelheim

    Head and neck squamous cell carcinoma

    phase 1 other active

    1 trial

  6. 1505-0001

    Boehringer Ingelheim

    Metastatic pancreatic ductal adenocarcinoma (mPDAC)

    phase 1 other active

    1 trial

  7. 1507-0001

    Boehringer Ingelheim

    Healthy volunteer trial

    phase 1 other active

    1 trial

  8. 1509-0002

    Boehringer Ingelheim

    Healthy volunteer trial

    phase 1 other active

    1 trial

  9. 1509-0003

    Boehringer Ingelheim

    Type 1 interferonopathies

    phase 1 other active

    1 trial

  10. 1509-0007

    Boehringer Ingelheim

    Healthy volunteer trial

    phase 1 other active

    1 trial

  11. 1509-0010

    Boehringer Ingelheim

    Healthy volunteer trial

    phase 1 other active

    1 trial

  12. 1509-0014

    Boehringer Ingelheim

    Healthy volunteer trial

    phase 1 other active

    1 trial

  13. 1516-0001

    Boehringer Ingelheim

    Healthy volunteer trial

    phase 1 other active

    1 trial

  14. 1516-0002

    Boehringer Ingelheim

    Healthy volunteer trial

    phase 1 other active

    1 trial

  15. 1516-0003

    Boehringer Ingelheim

    Attention deficit hyperactivity disorder, Borderline personality disorder

    phase 1 other active

    1 trial

  16. 1516-0004

    Boehringer Ingelheim

    Healthy volunteer trial

    phase 1 other active

    1 trial

  17. 1519-0001

    Boehringer Ingelheim

    Healthy volunteer trial

    phase 1 other active

    1 trial

  18. 1519-0002

    Boehringer Ingelheim

    Healthy volunteer trial

    phase 1 other active

    1 trial

  19. 1519-0004

    Boehringer Ingelheim

    Healthy volunteer trial

    phase 1 other active

    1 trial

  20. 1524-0001

    Boehringer Ingelheim

    Metabolic Dysfunction-associated Steatohepatitis

    phase 1 other active

    1 trial

  21. 1526-0001

    Boehringer Ingelheim

    Healthy volunteer trial

    phase 1 other active

    1 trial

  22. 1527-0001

    Boehringer Ingelheim

    Melanoma, Solid tumours

    phase 1 other active

    1 trial

  23. 1530-0001

    Boehringer Ingelheim

    Healthy volunteer trial

    phase 1 other active

    1 trial

  24. 1530-0002

    Boehringer Ingelheim

    Healthy volunteer trial

    phase 1 other active

    1 trial

  25. 1533-0001

    Boehringer Ingelheim

    Healthy volunteer trial

    phase 1 other active

    1 trial

  26. 1538-0001

    Boehringer Ingelheim

    advanced, unresectable and/or metastatic solid tumors

    phase 1 other active

    1 trial

  27. 1543-0001

    Boehringer Ingelheim

    healthy volunteer trial

    phase 1 other active

    1 trial

  28. 2001-0001

    Boehringer Ingelheim

    Advanced relapsed or refractory ovarian cancer, Advanced relapsed or refractory endometrial cancer, Advanced relapsed or refractory germ cell tumours

    phase 1 other active

    1 trial

  29. 2007-0001

    Boehringer Ingelheim

    Healthy volunteer trial

    phase 1 other active

    1 trial

  30. 2012-0001

    Boehringer Ingelheim

    unresectable advanced or metastatic solid cancer

    phase 1 other active

    1 trial

  31. A study in healthy men to test how BI 1569912 is processed in the body

    Boehringer Ingelheim

    Healthy volunteer trial

    phase 1 other active

    1 trial

  32. A study in healthy men to test how BI 1584862 is processed in the body

    Boehringer Ingelheim

    Healthy volunteer trial

    phase 1 other active

    1 trial

  33. A study in healthy people to compare two different Sifrol® tablets

    Boehringer Ingelheim

    Pharmacokinetic trial

    phase 1 other active

    1 trial

  34. A study in healthy people to compare two tablet formulations of pramipexole

    Boehringer Ingelheim

    Healthy volunteer trial

    phase 1 other active

    1 trial

  35. A study in healthy people to test how vicadrostat affects the heart

    Boehringer Ingelheim

    Healthy volunteer trial

    phase 1 other active

    1 trial

  36. BI 1015550, NERANDOMILAST

    Boehringer Ingelheim

    Healthy volunteer trial

    phase 1 small molecule active

    1 trial

  37. BI 3011441

    Boehringer Ingelheim

    Solid Tumors, KRAS Mutation

    phase 1 small molecule completed

    1 trial

  38. BI 695502

    Boehringer Ingelheim

    Healthy

    phase 1 small molecule completed

    1 trial

  39. BI 765063

    Boehringer Ingelheim

    Head and Neck Squamous Cell Carcinoma (HNSCC)

    phase 1 small molecule active

    1 trial

  40. BI 905711

    Boehringer Ingelheim

    Gastrointestinal Neoplasms

    phase 1 small molecule completed

    1 trial

  41. KISIMA-02 vaccine-based immunotherapy for patients with pancreatic cancer

    Boehringer Ingelheim

    G12D/G12V Pancreatic Ductal Adenocarcinoma

    phase 1 other active

    1 trial

  42. Lendormin tablet

    Boehringer Ingelheim

    Healthy

    phase 1 small molecule completed

    1 trial

  43. Spesolimab

    Boehringer Ingelheim

    Psoriasis

    phase 1 small molecule completed

    1 trial

  44. Afatinib

    Boehringer Ingelheim

    Carcinoma, Non-Small-Cell Lung

    approved small molecule completed

    1 trial

  45. Spesolimab

    Boehringer Ingelheim

    Generalized Pustular Psoriasis

    approved small molecule active

    3 trials

  46. Telmisartan

    Boehringer Ingelheim

    Cardiovascular Diseases

    approved small molecule completed

    1 trial

  47. metformin

    Boehringer Ingelheim

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial

  48. telmisartan

    Boehringer Ingelheim

    Hypertension

    approved small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Boehringer Ingelheim have?

193 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.